Recent studies suggested that NDRG1 positively regulates and stabilizes DNA repair enzymes MGMT, APEX1, and PKNP, thereby driving temozolomide (TMZ) resistance in human glioblastoma and acute lymphoblastic leukemia (AML) [32, 33]. Here, NDRG1 is linked to acute lymphoblastic leukemia.